DAVIDSON KEMPNER CAPITAL MANAGEMENT LP - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is and the CUSIP is 29664WAB1. A total of 22 filers reported holding ESPERION THERAPEUTICS INC NE in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q3 2023$16,016,500
+6.0%
31,100,000
+0.2%
0.25%
-19.6%
Q2 2023$15,106,073
+60.1%
31,025,000
+24.1%
0.32%
+97.5%
Q1 2023$9,432,500
+69770.4%
25,000,0000.0%0.16%
+7900.0%
Q4 2022$13,500
-99.9%
25,000,000
+4.2%
0.00%
-99.2%
Q3 2022$13,275,000
+1.7%
24,000,0000.0%0.24%
+7.5%
Q2 2022$13,050,000
+7.5%
24,000,0000.0%0.23%
+44.9%
Q1 2022$12,135,000
-3.2%
24,000,0000.0%0.16%
-15.7%
Q4 2021$12,540,00024,000,0000.18%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q2 2022
NameSharesValueWeighting ↓
PenderFund Capital Management Ltd. 29,679,000$23,720,0007.42%
SILVERBACK ASSET MANAGEMENT LLC 11,750,000$6,487,1750.92%
DCF Advisers, LLC 1,550,000$884,0000.57%
Context Capital Management, LLC 14,764$8,274,0000.56%
AGF Investments LLC 7,000,000$3,872,0000.36%
WHITEBOX ADVISORS LLC 19,600,000$10,682,0000.30%
Pentwater Capital Management LP 46,411,000$26,134,0000.29%
TENOR CAPITAL MANAGEMENT Co., L.P. 20,000,000$11,591,0000.27%
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 24,000,000$13,275,0000.24%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 14,900,000$8,493,0000.12%
View complete list of ESPERION THERAPEUTICS INC NE shareholders